CD38 splice variants and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 31, 2011
Grant Date -
Sep 15, 2005
app pub date -
Feb 10, 2005
filing date -
Feb 13, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides for a substantially purified polypeptide referred to herein as CD38JL that is a CD38 splice variant comprised of the polypeptide of SEQ ID NO: 1 or a fragment thereof. The invention also provides methods for treating preventing and diagnosing disorders associated with expression of CD38JL.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully